803
Participants
Start Date
October 31, 2012
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
Bivalirudin
Bivalirudin is an anticoagulant that binds directly to thrombin in a bivalent and reversible fashion.
Unfractionated Heparin
Unfractionated heparin is an anticoagulant.
Universitätsklinik Bern, Bern
St. Antonius Ziekenhuis, Nieuwegein
Asklepios St. Georg Hamburg, Hamburg
Ospedale San Raffaele U.O. Cardiologia Interventistica, Milan
Universitätsklinikum Hamburg-Eppendorf, Hamburg
CHU Jean Minjoz, Service de Cardiologie, Besançon
Klinikum links der Weser Bremen, Bremen
Medizinische Hochschule Hannover, Hanover
CHU de Toulouse, Toulouse
Clinique Pasteur, Unité de Cardiologie Interventionnelle, Toulouse
Elisabeth-Krankenhaus Essen, Essen
Universitätsklinikum Bonn, Bonn
Helios Heart Center Siegburg, Siegburg
Universitätsmedizin der Johannes Gutenberg-Universitat Mainz, Mainz
Azienda Ospedaliero-Universitaria Pisana, Pisa
Department of Cardiology, CHRU Lille, Lille
Centre Hospitalier de Lyon, Bron
Service de Cardiologie, Centre Hospitalo-Universitaire, Hôpital Charles-Nicolle, Rouen
Freiburg University, Freiburg im Breisgau
Deutsches Herzzentrum München, München
LMU Munich, Klinikum der Universität München, Munich
Institut Hospitalier Jacques Cartier, Massy
Ferraroto Hospital, University of Catania, Catania
Montreal Heart Institute, Montreal
St. Paul´s Hospital Providence Health Care, Vancouver
University Heart Centre, Clinic of Inner Medicine 1 Cardiology, Jena
Universität Leipzig - Herzzentrum GmbH, Leipzig
Azienda Ospedaliera San Camillo-Forlanini, Roma
Policlinico Umberto I, Università La Sapienza, Roma
University Medical Center Utrecht, Utrecht
Cardiology University Hospital Basel, Basel
The Royal Sussex County Hospital, Brighton
Hammersmith Hospital, London
Lead Sponsor
The Medicines Company
INDUSTRY